These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15372315)

  • 1. Prophylaxis and treatment of invasive candidiasis in the intensive care setting.
    Ostrosky-Zeichner L
    Eur J Clin Microbiol Infect Dis; 2004 Oct; 23(10):739-44. PubMed ID: 15372315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive candidiasis in the intensive care unit.
    Ostrosky-Zeichner L; Pappas PG
    Crit Care Med; 2006 Mar; 34(3):857-63. PubMed ID: 16505666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida prophylaxis and therapy in the ICU.
    Echeverria PM; Kett DH; Azoulay E
    Semin Respir Crit Care Med; 2011 Apr; 32(2):159-73. PubMed ID: 21506052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
    Hollenbach E
    Mycoses; 2008 Sep; 51 Suppl 2():25-45. PubMed ID: 18721330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
    Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
    Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal therapy for neonatal candidiasis.
    Zaoutis T; Walsh TJ
    Curr Opin Infect Dis; 2007 Dec; 20(6):592-7. PubMed ID: 17975409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of invasive candidiasis in critically ill patients.
    Blot S; Vandewoude K
    Drugs; 2004; 64(19):2159-75. PubMed ID: 15456333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MSG-01: A randomized, double-blind, placebo-controlled trial of caspofungin prophylaxis followed by preemptive therapy for invasive candidiasis in high-risk adults in the critical care setting.
    Ostrosky-Zeichner L; Shoham S; Vazquez J; Reboli A; Betts R; Barron MA; Schuster M; Judson MA; Revankar SG; Caeiro JP; Mangino JE; Mushatt D; Bedimo R; Freifeld A; Nguyen MH; Kauffman CA; Dismukes WE; Westfall AO; Deerman JB; Wood C; Sobel JD; Pappas PG
    Clin Infect Dis; 2014 May; 58(9):1219-26. PubMed ID: 24550378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit.
    Smith JA; Kauffman CA
    Crit Care Med; 2010 Aug; 38(8 Suppl):S380-7. PubMed ID: 20647796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echinocandins: a wealth of choice--how clinically different are they?
    Zaas AK
    Curr Opin Infect Dis; 2008 Aug; 21(4):426-32. PubMed ID: 18594297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic strategies in intensive care units].
    Eggimann P
    Med Mal Infect; 2007; 37 Suppl 2():5-8. PubMed ID: 17933658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Strategies for antifungal treatment failure in intensive care units].
    Arens C; Bernhard M; Koch C; Heininger A; Störzinger D; Hoppe-Tichy T; Hecker M; Grabein B; Weigand MA; Lichtenstern C
    Anaesthesist; 2015 Sep; 64(9):643-58. PubMed ID: 26349425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive candidiasis in the intensive care unit.
    Krishnan S; Ostrosky-Zeichner L
    Hosp Pract (1995); 2010 Apr; 38(2):82-91. PubMed ID: 20469617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy of candidemia and invasive candidiasis according to guidelines].
    Glöckner A
    Mycoses; 2010 May; 53 Suppl 1():30-5. PubMed ID: 20433654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Candida infections in the adult intensive care unit.
    Cruciani M; Serpelloni G
    Expert Opin Pharmacother; 2008 Feb; 9(2):175-91. PubMed ID: 18201143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of invasive Candida infections in non-neutropenic critically ill patients: from prophylaxis to early therapy.
    Garnacho-Montero J; Díaz-Martín A; Cayuela-Dominguez A
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S137-41. PubMed ID: 19013338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPICO 2.0 project. Development of educational therapeutic recommendations using the DELPHI technique on invasive candidiasis in critically ill adult patients in special situations.
    Zaragoza R; Ferrer R; Maseda E; Llinares P; Rodriguez A;
    Rev Iberoam Micol; 2014; 31(3):157-75. PubMed ID: 25113990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical nystatin prophylaxis: a likely viable measure for reducing impact of candidemia in neurosurgical patients with early tracheostomy intubation. Author's response.
    Puntillo F; Giglio M
    Crit Care; 2013; 17(1):414. PubMed ID: 25237682
    [No Abstract]   [Full Text] [Related]  

  • 20. Candidemia and invasive candidiasis: a review of the literature for the burns surgeon.
    Ha JF; Italiano CM; Heath CH; Shih S; Rea S; Wood FM
    Burns; 2011 Mar; 37(2):181-95. PubMed ID: 20395056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.